Initialising ...
Initialising ...
Initialising ...
Initialising ...
Initialising ...
Initialising ...
Initialising ...
Katabuchi, Tatsuya*; Sato, Yaoki*; Takebe, Karin*; Igashira, Masayuki*; Umezawa, Seigo*; Fujioka, Ryo*; Saito, Tatsuhiro*; Iwamoto, Nobuyuki
Journal of Nuclear Science and Technology, 6 Pages, 2024/00
Times Cited Count:0 Percentile:0.18(Nuclear Science & Technology)Maamoun, I.; Tokunaga, Kohei; Dohi, Terumi; Kanno, Futoshi*; Falyouna, O.*; Eljamal, O.*; Tanaka, Kazuya
Frontiers in Nuclear Engineering (Internet), 2, p.1142823_1 - 1142823_17, 2023/03
Recently, the rapid development of nuclear power technologies and the continuous energy demand around the world exhibited massive amounts of contaminated water with radionuclides. Technetium-99 (Tc) is one of the long-lived radionuclides with a highly mobile anionic form (Tc(VII)) in aqueous solutions. Hence, the rapid and efficient Tc(VII) removal from radioactive water has emerged as a challenging issue. In this work, bimetallic nickel/iron nanoparticles (Ni/Fe) were prepared to enhance the immobilization of rhenium (Re(VII)) from aqueous solutions, as the surrogate of Tc(VII).
Tanaka, Kazuya; Kozai, Naofumi; Yamasaki, Shinya*; Onuki, Toshihiko; Kaplan, D. I.*; Grambow, B.
Applied Clay Science, 182, p.105282_1 - 105282_8, 2019/12
Times Cited Count:16 Percentile:67.61(Chemistry, Physical)In this study, Ni-Zn layered hydroxide salt (LHS) was used for adsorption experiments of ReO, as a surrogate of TcO, in aqueous solutions with various initial Re and sodium salt concentrations. The maximum adsorption amount of Re was estimated at 127.7 mg/g (6.86 10 eq/g) by fitting adsorption isotherm of ReO to Langmuir plot. The adsorption of ReO at neutral pH was a reversible process by anion exchange, and decreased with increasing Cl, NO and SO in solution. EXAFS analysis indicated that ReO was adsorbed as an outer-sphere complex on Ni-Zn LHS. The Ni-Zn LHS is a more robust adsorbent for ReO than the Mg-Al LDH in terms of solution pH and tolerance to competing anions, and may be an effective alternative to the traditional and more limited method of removing aqueous TcO by reductive precipitation.
Suzudo, Tomoaki; Yamaguchi, Masatake; Hasegawa, Akira*
Journal of Nuclear Materials, 467(Part 1), p.418 - 423, 2015/12
Times Cited Count:45 Percentile:96.77(Materials Science, Multidisciplinary)Tungsten is expected to be a promising plasma-facing material for future fusion devices, but radiation-induced precipitation (RIP), which leads the material to hardening, is a concern at their practical use. One of the keys to accurate prediction of the emergence of RIP is migration of solute atoms, rhenium and osmium, that are produced by nuclear transmutation through irradiation. We conduct a series of numerical simulations using an atomic kinetic Monte Carlo method and investigate the migration of these solute atoms in the form of tungsten-rhenium and tungsten-osmium mixed dumbbells, considered to be the most efficient "carriers" of the solute atoms. We find that the low rotation energy barrier of these mixed dumbbells leading to three-dimensional migration greatly influences their diffusivities. The result also suggests that, although these dumbbells have three-dimensional motion, one cannot simply reduce their migration behavior to that of vacancy-like spherical objects.
Hashimoto, Kazuyuki; Wan, K. W. H. B. B.*; Matsuoka, Hiromitsu
Journal of Nuclear and Radiochemical Sciences, 6(3), p.193 - 196, 2005/12
The radioisotopes of rhenium (Re and Re) are attractive radionuclides for radiotherapy because of their energetic beta particles and gamma rays suitable for imaging. Mercaptoacetyltriglycine, MAG3 (NS ligand), is a useful bifunctional ligand in labeling monoclonal antibodies with metallic radionuclides. In this study, the labeling of MAG3 with carrier-free Re from a W/Re generator was investigated in detail. The Re-MAG3 complex was synthesized by the direct labeling method and by the indirect labeling method using a transfer ligand (citric acid or gluconic acid). The dependence of the labeling yield upon the reaction conditions such as the concentrations of tin(II) chloride dihydrate as a reducing agent, S-benzoyl MAG3 and the transfer ligand, pH, temperature, reaction time and the addition of a carrier was examined. The labeling yield of Re-MAG3 synthesized by the all method was over 90% under the optimum conditions.
Ogawa, Kazuma*; Mukai, Takahiro*; Arano, Yasushi*; Ono, Masahiro*; Hanaoka, Hirofumi*; Ishino, Seigo*; Hashimoto, Kazuyuki; Nishimura, Hiroshi*; Saji, Hideo*
Bioconjugate Chemistry, 16(4), p.751 - 757, 2005/07
Times Cited Count:61 Percentile:86.86(Biochemical Research Methods)Rhenium-186-1-hydroxyethylidene-1,1-diphosphonate (Re-HEDP) has been used for the palliation of metastatic bone pain. Delayed blood clearance and high gastric uptake of radioactivity have been observed upon injection, due to the instability of Re-HEDP in vivo. In this study, on the basis of the concept of bifunctional radiopharmaceuticals, we designed a stable Re-mercaptoacetylglycylglycylglycine (MAG3) complex-conjugated bisphosphonate (Re-MAG3-HBP). After purification by HPLC, Re-MAG3-HBP was synthesized with a radiochemical purity of over 95%. In biodistribution experiments, the radioactivity level ofRe-MAG3-HBP in bone was significantly higher than that of Re-HEDP. Blood clearance of Re-MAG3-HBP was faster than that of Re-HEDP. In addition, the gastric accumulation of Re-MAG3-HBP radioactivity was lower than that of Re-HEDP. In conclusion, Re-MAG3-HBP is expected to be a useful radiopharmaceutical for the palliation of metastatic bone pain.
Ogawa, Kazuma*; Mukai, Takahiro*; Arano, Yasushi*; Hanaoka, Hirofumi*; Hashimoto, Kazuyuki; Nishimura, Hiroshi*; Saji, Hideo*
Journal of Labelled Compounds and Radiopharmaceuticals, 47(11), p.753 - 761, 2004/11
Times Cited Count:28 Percentile:61.65(Biochemical Research Methods)no abstracts in English
Uehara, Tomoya*; Koike, Miho*; Nakata, Hideo*; Miyamoto, Shigehiko*; Motoishi, Shoji; Hashimoto, Kazuyuki; Oku, Naoto*; Nakayama, Morio*; Arano, Yasushi*
Nuclear Medicine and Biology, 30(3), p.327 - 334, 2003/04
Times Cited Count:20 Percentile:50.16(Radiology, Nuclear Medicine & Medical Imaging)no abstracts in English
Kobayashi, Katsutoshi; Motoishi, Shoji; Terunuma, Kuzuo; Rauf, A. A.*; Hashimoto, Kazuyuki
Radiochemistry, 42(6), p.551 - 554, 2000/12
no abstracts in English
Ogawa, Kazuma*; Ono, Masahiro*; Fujioka, Yasushi*; Saji, Hideo*; Mukai, Takahiro*; Konishi, Junji*; Uehara, Tomoya*; Arano, Yasushi*; Onoma, Katsuyuki
Kaku Igaku, 37(5), P. 577, 2000/09
no abstracts in English
Tamura, Koji; Oba, Hironori; Shibata, Takemasa
JAERI-Tech 99-050, 8 Pages, 1999/07
no abstracts in English
*; *; *; *; *; Hashimoto, Kazuyuki; *
Journal of Radioanalytical and Nuclear Chemistry, 239(2), p.385 - 389, 1999/00
Times Cited Count:2 Percentile:21.17(Chemistry, Analytical)no abstracts in English
Proc. of Korea Atomic Industrial Forum,Inc., p.347 - 357, 1997/04
no abstracts in English
Hashimoto, Kazuyuki; S.Bagiawati*; S.Islam*
Radiochemistry, 39(5), p.389 - 393, 1997/00
no abstracts in English
Hashimoto, Kazuyuki; *
Top. Curr. Chem., 176, p.276 - 291, 1996/00
no abstracts in English
Morinaga, Masahiko*; Saito, Junichi*; Murata, Yoshinori*; Kano, Shigeki; *; Tachi, Yoshiaki; Inoue, Satoshi*
PNC TY9623 95-001, 165 Pages, 1995/03
None
Morinaga, Masahiko*; Kano, Shigeki; Inoue, Satoshi*; *; Tachi, Yoshiaki; *; *
PNC TY9623 94-004, 87 Pages, 1994/03
None
Morinaga, Masahiko*; Inoue, Satoshi*; Saito, Junichi*; *; *; Kano, Shigeki; Tachi, Yoshiaki
PNC TY9623 93-005, 134 Pages, 1993/03
None
; Kubota, Masumitsu; *; *
Radiochimica Acta, 63, p.33 - 36, 1993/00
no abstracts in English